The Gabelli Healthcare & Wellness Trust Common Shares of Beneficial Interest (GRX)

FairStock Score: 22/100 — RISKY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

As a value investor, I begin by asking what I own. GRX is not an operating company; it is a closed-end fund investing globally in healthcare and wellness stocks across all market caps, managed by Gabelli Funds. At the close on 2026-10-13, the shares were $9.68 against a 52-week range of $8.80 to $10.20, with a $137.2M market cap and a 7.03% dividend yield. FairStock’s price-based P/E is 16.98. FairStock’s Graham Number is $11.62, giving a 16.70% margin of safety. That suggests a modest valuation cushion. But the other signals are troubling. FairStock Score is 22/100. The Piotroski F-Score is 1/9 and the Altman Z-Score is 1.41, both weak, though those tools were built for operating companies and may not fit a fund perfectly. There is no Lynch category because only 0 years of filed annual results exist, versus the 3 needed. Revenue growth, profit growth, ROE, ROCE and D/E are all N/A, so I cannot verify durable earning power, balance-sheet strength, or growth. For a fund, the real moat is manager skill and disciplined capital allocation, not something I can confirm from these figures. The high yield could be attractive, but I cannot tell from the data whether it is covered. At 16.70% below Graham Number, price is not demanding, but weak scores and missing history keep it from being a clear bargain. I would need more filed results and distribution coverage before trusting intrinsic value.

In plain English: This is a closed-end fund that owns healthcare and wellness stocks from around the world. Based on the limited numbers available, the business looks weak: it pays a high income distribution, but its financial health scores are low and it lacks a long filed record. The price looks about fair or slightly cheap compared with one simple value estimate, but not clearly cheap given the weak signals.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer